These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15576973)

  • 21. Raloxifene, tamoxifen and vascular tone.
    Leung FP; Tsang SY; Wong CM; Yung LM; Chan YC; Leung HS; Yao X; Huang Y
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):809-13. PubMed ID: 17600563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].
    Maeda T; Ke HZ; Simmons H; Thompson D
    Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T; Mizunuma H
    Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of hormone-related cancers: breast cancer.
    Dunn BK; Wickerham DL; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Delaying degeneration or promoting regeneration. 2 successful strategies in osteoporosis].
    MMW Fortschr Med; 2004 Mar; 146(10):46. PubMed ID: 15347088
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug treatment for the treatment of primary osteoporosis].
    Halbekath J
    Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):453-60. PubMed ID: 10996934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic agents for disorders of bone and calcium metabolism: Bazedoxifene].
    Chaki O
    Clin Calcium; 2007 Jan; 17(1):30-5. PubMed ID: 17211091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raloxifene use in clinical practice: efficacy and safety.
    Goldstein SR; Duvernoy CS; Calaf J; Adachi JD; Mershon JL; Dowsett SA; Agnusdei D; Stuenkel CA
    Menopause; 2009; 16(2):413-21. PubMed ID: 19092711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining the role of raloxifene for the prevention of breast cancer.
    Kalidas M; Hilsenbeck S; Brown P
    J Natl Cancer Inst; 2004 Dec; 96(23):1731-3. PubMed ID: 15572750
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is raloxifene ready to be used for prevention of breast cancer?
    Powles TJ
    Int J Fertil Womens Med; 2006; 51(5):203-4. PubMed ID: 17269585
    [No Abstract]   [Full Text] [Related]  

  • 32. Estrogens and SERMs in coronary heart disease.
    Regitz-Zagrosek V; Wintermantel TM; Schubert C
    Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy.
    Gennari L
    Expert Opin Pharmacother; 2009 Sep; 10(13):2209-20. PubMed ID: 19640205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology and clinical applications of selective estrogen receptor modulators.
    Nath A; Sitruk-Ware R
    Climacteric; 2009 Jun; 12(3):188-205. PubMed ID: 19387883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormone replacement Up-to-date. Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis].
    Hosoi T
    Clin Calcium; 2007 Sep; 17(9):1419-23. PubMed ID: 17767033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Additional effect of SERM: central nervous system].
    Honjo H
    Clin Calcium; 2004 Oct; 14(10):69-72. PubMed ID: 15577134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology].
    Terán Dávila J; Teppa Garrán AD
    Ginecol Obstet Mex; 2005 Aug; 73(8):424-35. PubMed ID: 16304968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Not all SERMs are created equal.
    Goldstein SR
    Menopause; 2006; 13(3):325-7. PubMed ID: 16735926
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter by Choi et al regarding article, "Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors".
    Choi BG; Vilahur G; Badimon JJ
    Circulation; 2009 Oct; 120(17):e147; author reply e148. PubMed ID: 19858421
    [No Abstract]   [Full Text] [Related]  

  • 40. [Next generation selective estrogen receptor modulators].
    Chaki O
    Clin Calcium; 2006 Jan; 16(1):145-52. PubMed ID: 16397365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.